How to Prevent Heart Failure Readmission by Using Lung Impedance Device (HOPE-HF Study) — HOPE-HF  

Heart Failure Acute Clinical Trial

Official title: How to Prevent Heart Failure Readmission by Using Lung Impedance Device (HOPE-HF Study)

Status Not yet recruiting

Clinical Trial Summary

The readmission of Heart Failure (HF) patients for exacerbation HF within 30-day is unmet goal. The mail reason for readmission is excessive accumulation of fluid in patient's lung. According our data (1,2) around 40% of HF patient have excessive lung fluid at discharge from HF hospitalization ("unacceptable" residual congestion on discharge). In other words, around 40% patients are discharged from HF hospitalization prematurely when they are not ready to be discharged. Only 60% of HF patients are discharged from HF admission with "acceptable" level of residual pulmonary congestion (2). There are some techniques to assess "readiness" of HF patients for discharge. Pulmonary congestion (lung fluid accumulation) may be assessed non-invasively by measurement Brain Natriuretic Peptide (BNP), (3,4), by lung ultrasound (LUS), (5-7) and by Lung Impedance (LI) method (1,2). LUS is operator depended technique. LI and BNP techniques are most reliable methods (2) and easy to use.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Heart Failure
• Heart Failure Acute

• NCT number: NCT04080388
• Study type: Interventional
• Source: Hillel Yaffe Medical Center
• Contact: Michael Kleiner Shochat, MD, PhD
• Phone: 972-50-6246926
• Email: shochat1@gmail.com
• Status: Not yet recruiting
• Phase: Phase 3
• Start date: September 2019
• Completion date: September 2021